Showing results (1331-1340 of 1,614) with videos related to
Sort By:
Pageof 162
RSC Medicinal Chemistry|July 5, 2021
Proline pre-conditioning of cell monolayers increases post-thaw recovery and viability by distinct mechanisms to other osmolytesTrisha L Bailey, Juan Ramon Hernandez-Fernaud, Matthew I GibsonRSC Medicinal Chemistry|July 5, 2021
A mimotope attached to an ITIM-SHP-1 interaction inhibitory peptide boosts immune response and efficacyKoushik Roy, Syamal Roy, Siddhartha RoyRSC Medicinal Chemistry|July 15, 2021
Cyclisation strategies for stabilising peptides with irregular conformationsQuynh Ngoc Vu, Reginald Young, Haritha Krishna Sudhakar, et al.RSC Medicinal Chemistry|July 15, 2021
Amino alcohol acrylonitriles as broad spectrum and tumour selective cytotoxic agentsJennifer R Baker, Cecilia C Russell, Jayne Gilbert, et al.RSC Medicinal Chemistry|June 14, 2021
Cucurbit[8]uril-based supramolecular hydrogels for biomedical applicationsZeyu Wang, Mingju Shui, Ian W Wyman, et al.RSC Medicinal Chemistry|June 14, 2021
Reactivity of N-acyl hydrazone probes with the mammalian proteomeTyler A Shaw, Megan H Powdrill, Allison R Sherratt, et al.RSC Medicinal Chemistry|June 14, 2021
Nanoscale, automated, high throughput synthesis and screening for the accelerated discovery of protein modifiersKai Gao, Shabnam Shaabani, Ruixue Xu, et al.RSC Medicinal Chemistry|May 28, 2021
Medicinal chemistry updates on quinoline- and endoperoxide-based hybrids with potent antimalarial activityAmad Uddin, Meenal Chawla, Iram Irfan, et al.RSC Medicinal Chemistry|May 28, 2021
Identification of P218 as a potent inhibitor of Mycobacterium ulcerans DHFRGustavo P Riboldi, Rachael Zigweid, Peter J Myler, et al.RSC Medicinal Chemistry|May 28, 2021
Identification of LASSBio-1945 as an inhibitor of SARS-CoV-2 main protease (MPRO) through in silico screening supported by molecular docking and a fragment-based pharmacophore modelLucas S Franco, Rodolfo C Maia, Eliezer J BarreiroPageof 162